文献速递介入外周血管腹部DSA

血管内离子交换化疗过滤装置在肝动脉内化疗模型中减少多柔比星的非靶向暴露

Endovascular Ion Exchange Chemofiltration Device Reduces Off-Target Doxorubicin Exposure in a Hepatic Intra-arterial Chemotherapy Model.
PubMed 文献 · Radiol Imaging Cancer · 2019-09-27

在六头正常肝脏猪的临床前模型中,肝动脉内灌注多柔比星时于肝静脉流出道置入离子交换化疗过滤装置(ChemoFilter),可显著降低全身多柔比星暴露、峰值浓度及心脏和肾脏的药物蓄积,装置耐受良好,未见血流动力学、血栓或免疫学并发症。

要点

  • 肝动脉内化疗时于肝静脉流出道置入ChemoFilter装置,可降低多柔比星全身暴露和心脏蓄积。
  • 装置耐受良好,未观察到血流动力学、血栓或免疫学并发症。
  • 荧光成像证实多柔比星在体内与ChemoFilter装置结合。

关键影像表现/征象

  • 荧光成像证实多柔比星在体内与ChemoFilter装置结合。
  • ChemoFilter装置耐受良好,未观察到血流动力学、血栓或免疫学并发症。

诊断标准与关键数值

  • 治疗组较对照组全身多柔比星暴露显著降低(P < .009)。
  • 治疗组峰值多柔比星浓度降低31%(P < .01),达峰时间延长(P < .03)。
  • 心脏组织多柔比星蓄积显著降低(P < .001),肾脏显著降低(P < .022)。
  • 心脏平均组织浓度:治疗组14.2 μg/g ± 1.9 vs 对照组26.0 μg/g ± 1.8。
  • 肾脏平均组织浓度:治疗组46.4 μg/g ± 4.6 vs 对照组172.6 μg/g ± 40.2;肝脏:治疗组217.0 μg/g ± 5.1 vs 对照组236.8 μg/g ± 9.0。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To determine if endovascular chemofiltration with an ionic device (ChemoFilter [CF]) can be used to reduce systemic exposure and off-target biodistribution of doxorubicin (DOX) during hepatic intra-arterial chemotherapy (IAC) in a preclinical model.

MATERIALS AND METHODS: Hepatic IAC infusions were performed in six pigs with normal livers. Animals underwent two 10-minute intra-arterial infusions of DOX (200 mg) into the common hepatic artery. Both the treatment group and the control group received initial IAC at 0 minutes and a second dose at 200 minutes. Prior to the second dose, CF devices were deployed in and adjacent to the hepatic venous outflow tract of treatment animals. Systemic exposure to DOX was monitored via blood samples taken during IAC procedures. After euthanasia, organ tissue DOX concentrations were analyzed. Alterations in systemic DOX exposure and biodistribution were compared by using one-tailed t tests.

RESULTS: CF devices were well tolerated, and no hemodynamic, thrombotic, or immunologic complications were observed. Animals treated with a CF device had a significant reduction in systemic exposure when compared with systemic exposure in the control group (P <.009). Treatment with a CF device caused a significant decrease in peak DOX concentration (31%, P <.01) and increased the time to maximum concentration (P <.03). Tissue analysis was used to confirm significant reduction in DOX accumulation in the heart and kidneys (P <.001 and P <.022, respectively). Mean tissue concentrations in the heart, kidneys, and liver of animals treated with CF compared with those in control animals were 14.2 μg/g ± 1.9 (standard deviation) versus 26.0 μg/g ± 1.8, 46.4 μg/g ± 4.6 versus 172.6 μg/g ± 40.2, and 217.0 μg/g ± 5.1 versus 236.8 μg/g ± 9.0, respectively. Fluorescence imaging was used to confirm in vivo DOX binding to CF devices.

CONCLUSION: Reduced systemic exposure and heart bioaccumulation of DOX during local-regional chemotherapy to the liver can be achieved through in situ adsorption by minimally invasive image-guided CF devices.© RSNA, 2019.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Yee C, McCoy D, Yu J, et al. Endovascular Ion Exchange Chemofiltration Device Reduces Off-Target Doxorubicin Exposure in a Hepatic Intra-arterial Chemotherapy Model. Radiol Imaging Cancer. 2019. PMID: 32300759. doi:10.1148/rycan.2019190009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。